相关产品推荐更多 >

PE/Cy7 Anti-human/ dog CD132 Antibody *TUGh4*/PE/Cy7 Anti-human/ dog CD132 Antibody *TUGh4*/PE/Cy7 Anti-human/ dog CD132 Antibody *TUGh4*
询价
A Disintegrin And Metalloproteinase With Thrombospondin Motifs 14 (ADAMTS14) Antibody/A Disintegrin And Metalloproteinase With Thrombospondin Motifs 14 (ADAMTS14) Antibody/A Disintegrin And Metalloproteinase With Thrombospondin Motifs 14 (ADAMTS14) A
询价
TMEM91 Antibody (FITC)/TMEM91 Antibody (FITC)/TMEM91 Antibody (FITC)
询价
HA tag 抗体:偶联APC |HA tag Antibody: APC
询价
Il12b单克隆抗体 | Il12b monoclonal antibody
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 克隆性:
多克隆
- 抗体英文名:
UHRF1 Antibody ( FLJ21925, ICBP90, MGC138707, Np95, RNF106, hNP95)
- 规格:
100 ug
产品名称:UHRF1抗体|UHRF1 Antibody ( FLJ21925, ICBP90, MGC138707, Np95, RNF106, hNP95)
【产品形式】:艾美捷为您提供的UHRF1抗体产品为无色溶液形式,含有100 ug抗体.该产品浓度为1 mg/ml,溶解于包含有50% 甘油和0.02%NaN3的PBS缓冲液(pH 7.3)中.请在收到该UHRF1抗体产品后,将其置于-20 °C冷冻保存,建议分装使用以避免反复冻融.
【背景资料】:UHRF1, also named as ICBP90, NP95 and RNF106, is a putative E3 ubiquitin protein ligase. It may participate in methylation dependent transcriptional regulation. UHRF1 binds to inverted 5’CCAAT3’ box 2 in the TOP2A promoter, and activates TOP2A expression. It is important for G1/S transition and may be involved in DNA repair and chromosomal stability. UHRF1’s ability to repress its direct target gene expression is dependent on PHD (UHRF1) binding to unmodified H3R2.
BioVision的公司总部在美丽的旧金山湾地区,它是全球生命科学公司的领导者.BioVision在开发和研究细胞凋亡检测分析、代谢检测方面具有 卓越的影响力.包括检测各种检测分析试剂盒、相关特色抗体、重组蛋白及细胞因子和酶等多种产品,以及其他创新的研究工具.其产品覆盖细胞凋亡研究、能量代 谢、细胞/组织蛋白提取、氧化应激与损伤、代谢与肥胖症、细胞增殖与毒性、信号转导、干细胞研究等领域.作为多家知名品牌的中国总代理以及中国区域代理, 艾美捷与BioVision一起为研究者们提供最好、最新的细胞生物学研究工具而不断扩大产品及服务质量.
点击:UHRF1抗体,查看更详细产品说明,更多应用、储存、价格、货期等信息请致电400-6800-868垂询BioVision中国区域授权总代理艾美捷科技有限公司。
关键词:UHRF1,UHRF1抗体
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验were significantly decreased. High expressions of Bcl-2 and Bax were detected in 1 and 2μmol/L arseni c trioxide-treated cells, these were 46%, 87.33% and 83.08%, 95.83% respecti vely, among which that of Bax was more significant. Arsenic trioxide treatment at 0.5μ
技术资料暂无技术资料 索取技术资料






